======= TAPBPL ======= == Gene Information == * **Official Symbol**: TAPBPL * **Official Name**: TAP binding protein like * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=55080|55080]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q9BX59|Q9BX59]] * **Interactions**: [[https://thebiogrid.org/search.php?search=TAPBPL&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20TAPBPL|Open PubMed]] * **OMIM**: [[https://omim.org/entry/607081|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Component of the antigen processing and presentation pathway, which binds to MHC class I coupled with beta2- microglobulin/B2M. Association between TAPBPR and MHC class I occurs in the absence of a functional peptide-loading complex (PLC). Expression seems to slow down and down-regulate MHC class I surface expression. {ECO:0000269|PubMed:23401559}. |C1-set| |V-set| |peptide antigen assembly with MHC class I protein complex| |MHC class I protein complex assembly| |negative regulation of antigen processing and presentation of peptide antigen via MHC class I| |regulation of antigen processing and presentation of peptide antigen via MHC class I| |negative regulation of antigen processing and presentation of peptide antigen| |peptide antigen assembly with MHC protein complex| |MHC class I protein complex binding| |regulation of antigen processing and presentation of peptide antigen| |MHC protein complex assembly| |negative regulation of antigen processing and presentation| |regulation of antigen processing and presentation| |antigen processing and presentation of peptide antigen via MHC class I| |antigen processing and presentation of peptide antigen| |antigen processing and presentation| |protein-containing complex binding| |negative regulation of immune system process| |Golgi membrane| |cellular protein-containing complex assembly| |endoplasmic reticulum membrane| |protein-containing complex assembly| |regulation of immune system process| |protein-containing complex subunit organization| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp458|Bisphenol S 100μM R08 exp458]]|-1.7| ^Gene^Correlation^ |[[:human genes:p:polr2j3|POLR2J3]]|0.474| Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 16285 * **Expression level (log2 read counts)**: 4.65 {{:chemogenomics:nalm6 dist.png?nolink |}}